When administering selegiline to a client, what is the nurse's best action concerning skin integrity?

When administering selegiline, focusing on the assessment of the client's skin integrity is crucial due to the potential for skin reactions associated with transdermal delivery systems, such as the selegiline patch. The medication is a monoamine oxidase inhibitor (MAOI), and while it is effective for treating conditions like depression, it can lead to local skin irritation, rashes, or other dermatological issues. By prioritizing the assessment of the skin, the nurse can identify reactions early on, manage any adverse effects promptly, and ensure the safety and comfort of the client.

This proactive approach is essential, especially since skin reactions could lead to complications if left unobserved. Educating clients about potential side effects is also important, but it follows after ensuring that the client’s condition is stable and there are no immediate issues with skin integrity. As such, focusing on the assessment offers direct benefits to patient care and addresses potential risks associated with the medication.